Moderately bullish activity in Novo Nordisk (NVO), with shares up 16c, or 0.45%, near $36.98. Options volume relatively light with 23k contracts traded and calls leading puts for a put/call ratio of 0.79, compared to a typical level near 0.7. Implied volatility (IV30) is higher by 0.5 points near 43.57,and below the 52wk median, suggesting an expected daily move of $1.02. Put-call skew steepened, indicating increased demand for downside protection.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVO:
- Eli Lilly Stock (LLY) Faces This Make-or-Break Test on April 10
- Novo Nordisk Advances DKK 15 Billion Share Buyback, Holds 0.6% in Treasury Shares
- Lexicon, Novo Nordisk announce initiation of LX9851 study
- $14 Generic Wegovy Coming to India as Novo Nordisk (NVO) Patent Expires
- Novo Nordisk Wins U.S. Approval for High‑Dose Wegovy to Deepen Obesity Franchise
